Human mesenchymal stromal cells enhance the immunomodulatory function of CD8 + CD28 − regulatory T cells

Qiuli Liu,Haiqing Zheng,Xiaoyong Chen,Yanwen Peng,Weijun Huang,Xiaobo Li,Gang Li,Wenjie Xia,Qiquan Sun,Andy Peng Xiang

DOI: https://doi.org/10.1038/cmi.2014.118

2014-01-01

Abstract:One important aspect of mesenchymal stromal cells (MSCs)-mediated immunomodulation is the recruitment and induction of regulatory T (Treg) cells. However, we do not yet know whether MSCs have similar effects on the other subsets of Treg cells. Herein, we studied the effects of MSCs on CD8 + CD28 − Treg cells and found that the MSCs could not only increase the proportion of CD8 + CD28 − T cells, but also enhance CD8 + CD28 − T cells' ability of hampering naive CD4 + T-cell proliferation and activation, decreasing the production of IFN-γ by activated CD4 + T cells and inducing the apoptosis of activated CD4 + T cells. Mechanistically, the MSCs affected the functions of the CD8 + CD28 − T cells partially through moderate upregulating the expression of IL-10 and FasL. The MSCs had no distinct effect on the shift from CD8 + CD28 + T cells to CD8 + CD28 − T cells, but did increase the proportion of CD8 + CD28 − T cells by reducing their rate of apoptosis. In summary, this study shows that MSCs can enhance the regulatory function of CD8 + CD28 − Treg cells, shedding new light on MSCs-mediated immune regulation.